These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 30747305
1. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study. McGowan K, Ware RS, Acton C, Ivanovski S, Johnson NW. Clin Oral Investig; 2019 Nov; 23(11):3967-3975. PubMed ID: 30747305 [Abstract] [Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P. Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661 [Abstract] [Full Text] [Related]
3. Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study. McGowan K, Acton C, Ivanovski S, Johnson NW, Ware RS. Oral Dis; 2019 May; 25(4):1107-1115. PubMed ID: 30674072 [Abstract] [Full Text] [Related]
5. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M. PLoS One; 2018 May; 13(7):e0201343. PubMed ID: 30048523 [Abstract] [Full Text] [Related]
9. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients. Coropciuc R, Coopman R, Garip M, Gielen E, Politis C, Van den Wyngaert T, Beuselinck B. Bone; 2023 May; 170():116722. PubMed ID: 36858337 [Abstract] [Full Text] [Related]
10. Full blood counts are not predictive of the risk of medication-related osteonecrosis of the jaws: a case-control study. McGowan K, Ware RS, Acton C, Ivanovski S, Johnson NW. Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Oct; 128(4):373-380. PubMed ID: 31097394 [Abstract] [Full Text] [Related]
12. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents? Ueda N, Nakashima C, Aoki K, Shimotsuji H, Nakaue K, Yoshioka H, Kurokawa S, Imai Y, Kirita T. Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886 [Abstract] [Full Text] [Related]
13. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses. Karna H, Gonzalez J, Radia HS, Sedghizadeh PP, Enciso R. Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314 [Abstract] [Full Text] [Related]
17. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ. Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135 [Abstract] [Full Text] [Related]